These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 10782027)
1. Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist. Hofer C; Sauerstein P; Wolter C; Scholz M; Hartung R; Breul J Urol Int; 2000; 64(1):18-23. PubMed ID: 10782027 [TBL] [Abstract][Full Text] [Related]
2. Total and free PSA: a methodical and clinical evaluation of five assays. Reiter W; Stieber P; Schmeller N; Nagel D; Hofmann K; Fateh-Moghadam A Anticancer Res; 1997; 17(6D):4759-65. PubMed ID: 9494603 [TBL] [Abstract][Full Text] [Related]
3. Influence of free-to-total prostate specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays. de la Taille A; Houlgatte A; Houdelette P; Goluboff ET; Berlizot P; Ricordel I Br J Urol; 1998 Sep; 82(3):389-92. PubMed ID: 9772876 [TBL] [Abstract][Full Text] [Related]
4. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology. Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696 [TBL] [Abstract][Full Text] [Related]
5. Utility of free/total prostate specific antigen (f/t PSA) ratio in diagnosis of prostate carcinoma. Thakur V; Singh PP; Talwar M; Mukherjee U Dis Markers; 2003-2004; 19(6):287-92. PubMed ID: 15258330 [TBL] [Abstract][Full Text] [Related]
6. Is free prostate-specific antigen helpful in the differential diagnosis of benign hyperplasia and cancer of the prostate? Reiter W; Stieber P; Schmeller N; Nagel D; Schambeck C; Fateh-Moghadam A Tumour Biol; 1997; 18(2):80-7. PubMed ID: 9222305 [TBL] [Abstract][Full Text] [Related]
7. The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: a validation study on a Turkish patient population in different age categories. Erol B; Gulpinar MT; Bozdogan G; Ozkanli S; Onem K; Mungan G; Bektas S; Tokgoz H; Akduman B; Mungan A Kaohsiung J Med Sci; 2014 Nov; 30(11):545-50. PubMed ID: 25458043 [TBL] [Abstract][Full Text] [Related]
8. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4-10 ng/ml. Martínez-Piñeiro L; Tabernero A; Contreras T; Madero R; Lozano D; López-Tello J; Alonso-Dorrego JM; Picazo ML; González Gancedo P; Martínez-Piñeiro JA; de La Peña JJ Eur Urol; 2000 Mar; 37(3):289-96. PubMed ID: 10720854 [TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. Okihara K; Cheli CD; Partin AW; Fritche HA; Chan DW; Sokoll LJ; Brawer MK; Schwartz MK; Vessella RL; Loughlin KR; Johnston DA; Babaian RJ J Urol; 2002 May; 167(5):2017-23; discussion 2023-4. PubMed ID: 11956430 [TBL] [Abstract][Full Text] [Related]
10. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer]. de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075 [TBL] [Abstract][Full Text] [Related]
11. The variation of percent free prostate-specific antigen determined by two different assays. Yang CR; Ou YC; Horng YY; Lee HS Anticancer Res; 2003; 23(1B):707-11. PubMed ID: 12680171 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of total prostate specific antigen and free to total prostate specific antigen ratio in the diagnosis of prostate cancer. Chakraborty L; Ahmed AN; Paul BK; Haque A; Ara A; Nabi S; Nessa M Mymensingh Med J; 2012 Jan; 21(1):98-102. PubMed ID: 22314462 [TBL] [Abstract][Full Text] [Related]
13. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. Catalona WJ; Partin AW; Slawin KM; Brawer MK; Flanigan RC; Patel A; Richie JP; deKernion JB; Walsh PC; Scardino PT; Lange PH; Subong EN; Parson RE; Gasior GH; Loveland KG; Southwick PC JAMA; 1998 May; 279(19):1542-7. PubMed ID: 9605898 [TBL] [Abstract][Full Text] [Related]
14. [Serum and urine prostate-specific antigen ratio: its value in the distinction between prostate cancer and adenoma when serum prostate-specific antigen level is between 4 and 10 ng/ml]. Irani J; Millet C; Levillain P; Doré B; Bégon F; Aubert J Chirurgie; 1997; 122(8-9):478-82. PubMed ID: 9616891 [TBL] [Abstract][Full Text] [Related]
15. [Significance and limitations of f/tPSA in differential diagnosis of prostate cancer with tPSA levels between 4 and 10 ng/ml]. Chen ZD; Wei SM; Cai SL Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):593-5. PubMed ID: 15265401 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of free-to-total prostate specific antigen (F/T PSA), prostate specific antigen density (PSAD) and (F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone. Milkovic B; Dzamic Z; Pejcic T; Kajmakovic B; Nikolic D; Cirovic D; Knezevic T; Dzamic D; Hadzi-Djokic J Ann Ital Chir; 2014; 85(5):448-53. PubMed ID: 25599711 [TBL] [Abstract][Full Text] [Related]
17. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml. Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333 [TBL] [Abstract][Full Text] [Related]
18. [Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients)]. de la Taille A; Houlgatte A; Houdelette P; Berlizot P; Ramirez J; Ricordel I Prog Urol; 1997 Apr; 7(2):240-5. PubMed ID: 9264766 [TBL] [Abstract][Full Text] [Related]
19. Can percent free prostate-specific antigen reduce the need for prostate biopsy? Lieberman S Eff Clin Pract; 1999; 2(6):266-71. PubMed ID: 10788024 [TBL] [Abstract][Full Text] [Related]
20. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer. Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]